Wednesday, July 30, 2025 at 6PM EDT
This 1-hour Webinar is comprised of eight (8) modules, each focusing on aspects of living with achondroplasia and offering practical recommendations for treatment from the recent 2025 international guidelines.Join us for a conversation featuring
Professor of Clinical Pediatrics
Division of Pediatric Endocrinology
Cincinnati Children’s Hospital Medical Center
University of Cincinnati College of Medicine
Cincinnati, Ohio
Medical Director
US - Achondroplasia
BioMarin Pharmaceutical, Inc.
San Rafael, California
Learning objectives:
To provide an overview of the 2025 international consensus guidelines for vosorotide in achondroplasia
To discuss how the guidelines provide important recommendations for vosoritide use in individuals with achondroplasia, from treatment decision-making, through initiation, follow-up and long-term monitoring
To illuminate how the guidelines help guide clinicians, individuals, and caregivers throughout the treatment journey
Register now
This educational program has been produced and fully funded by BioMarin.
Please note this Webinar will be recorded.
If you have questions or need any additional information about the Webinar, please contact us at questions@inbiopharma.com
BioMarin Pharmaceutical Inc. complies with the Open Payments Act and the PhRMA Guidelines.
